Online inquiry

IVTScrip™ mRNA-Human ACVR1B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK12477MR)

This product GTTS-WK12477MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ACVR1B protein. This product can be used in 1-cell stage cell (Blastomere)-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_004302.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 91
UniProt ID P36896
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACVR1B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK12477MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK24961MR IVTScrip™ mRNA-Human AREG, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AREG
GTTS-WK6342MR IVTScrip™ mRNA-Human PTN, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA PTN
GTTS-WK20579MR IVTScrip™ mRNA-Human ANGPT1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANGPT1
GTTS-WK17879MR IVTScrip™ mRNA-Human ANGPT1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANGPT1
GTTS-WK17579MR IVTScrip™ mRNA-Human ANGPT1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANGPT1
GTTS-WK18182MR IVTScrip™ mRNA-Human ANGPTL2, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ANGPTL2
GTTS-WK11276MR IVTScrip™ mRNA-Human ACVR1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACVR1
GTTS-WK18782MR IVTScrip™ mRNA-Human ANGPTL2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANGPTL2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →